CLINICAL TRIALS PROFILE FOR ROMAZICON
✉ Email this page to a colleague
All Clinical Trials for ROMAZICON
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00781482 ↗ | Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem | Withdrawn | Abiant, Inc. | Phase 4 | 1969-12-31 | This study will compare the interactions of a placebo and two FDA-approved sleeping medications, Eszopiclone (Lunesta) and Zolpidem (Ambien), with certain chemical receptors in the brain. We want to show that we can use positron emission tomography images to measure the binding of these medications to the receptors. |
NCT00781482 ↗ | Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem | Withdrawn | Sunovion | Phase 4 | 1969-12-31 | This study will compare the interactions of a placebo and two FDA-approved sleeping medications, Eszopiclone (Lunesta) and Zolpidem (Ambien), with certain chemical receptors in the brain. We want to show that we can use positron emission tomography images to measure the binding of these medications to the receptors. |
NCT00781482 ↗ | Positron Emission Tomography Assessment of the Central Nervous System Effects of Eszopiclone and Zolpidem | Withdrawn | Kettering Health Network | Phase 4 | 1969-12-31 | This study will compare the interactions of a placebo and two FDA-approved sleeping medications, Eszopiclone (Lunesta) and Zolpidem (Ambien), with certain chemical receptors in the brain. We want to show that we can use positron emission tomography images to measure the binding of these medications to the receptors. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ROMAZICON
Condition Name
Clinical Trial Locations for ROMAZICON
Trials by Country
Clinical Trial Progress for ROMAZICON
Clinical Trial Phase
Clinical Trial Sponsors for ROMAZICON
Sponsor Name